| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Peter S Nelson | Q100440151 |
| Lawrence D True | Q114402092 | ||
| P2093 | author name string | Javier Hernandez | |
| Ladan Fazli | |||
| Martin Gleave | |||
| Dean Troyer | |||
| Ian M Thompson | |||
| Sarah Hawley | |||
| Daniel W Lin | |||
| Ziding Feng | |||
| Peter R Carroll | |||
| Jeff Simko | |||
| Elizabeth Smith | |||
| James D Brooks | |||
| June M Chan | |||
| Jesse K McKenney | |||
| Xiaotun Zhang | |||
| Raymond Lance | |||
| Antonio Hurtado-Coll | |||
| Michelle Ferrari | |||
| Janet E Cowan | |||
| Rosario Mendez-Meza | |||
| Lisa F Newcomb | |||
| Kyle Kuchinsky | |||
| Imelda Tenggara | |||
| Janet Liew | |||
| Luis Crouch | |||
| Marlo Nicolas | |||
| P2860 | cites work | Mortality results from a randomized prostate-cancer screening trial | Q24601536 |
| Cancer statistics, 2010 | Q27860525 | ||
| Screening and prostate-cancer mortality in a randomized European study | Q29617485 | ||
| Tissue microarrays for high-throughput molecular profiling of tumor specimens | Q29618675 | ||
| Time-dependent ROC curves for censored survival data and a diagnostic marker | Q30600327 | ||
| Natural history of progression after PSA elevation following radical prostatectomy | Q33611613 | ||
| Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement | Q34288506 | ||
| Contemporary trends in low risk prostate cancer: risk assessment and treatment | Q34330041 | ||
| Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience | Q34394882 | ||
| Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations | Q34399633 | ||
| The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing | Q34689827 | ||
| Radical prostatectomy versus observation for localized prostate cancer | Q36194308 | ||
| Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy | Q36439622 | ||
| Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. | Q36836075 | ||
| Canary Prostate Active Surveillance Study: design of a multi-institutional active surveillance cohort and biorepository | Q37307609 | ||
| ETS gene fusions in prostate cancer: from discovery to daily clinical practice | Q37467056 | ||
| Adjuvant radiotherapy after radical prostatectomy: evidence and analysis. | Q37776349 | ||
| Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results | Q39692137 | ||
| Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy | Q39724803 | ||
| Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial | Q39863870 | ||
| Pathologic stage migration has slowed in the late PSA era. | Q51110991 | ||
| Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. | Q53864503 | ||
| Judging New Markers by Their Ability to Improve Predictive Accuracy | Q73361138 | ||
| Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in | Q79557156 | ||
| Information content of five nomograms for outcomes in prostate cancer | Q81471886 | ||
| P433 | issue | 1 | |
| P921 | main subject | biomarker | Q864574 |
| prostate cancer | Q181257 | ||
| P304 | page(s) | 39-44 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Advances in Anatomic Pathology | Q15753011 |
| P1476 | title | A model for the design and construction of a resource for the validation of prognostic prostate cancer biomarkers: the Canary Prostate Cancer Tissue Microarray | |
| P478 | volume | 20 |
| Q40978920 | A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer |
| Q37087108 | Acid ceramidase induces sphingosine kinase 1/S1P receptor 2-mediated activation of oncogenic Akt signaling |
| Q38833458 | Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH. |
| Q49787389 | Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer |
| Q35690915 | Evaluation of ERG and SPINK1 by Immunohistochemical Staining and Clinicopathological Outcomes in a Multi-Institutional Radical Prostatectomy Cohort of 1067 Patients. |
| Q42845103 | Loss of Expression of AZGP1 Is Associated With Worse Clinical Outcomes in a Multi-Institutional Radical Prostatectomy Cohort |
| Q36192598 | MUC1 Expression by Immunohistochemistry Is Associated with Adverse Pathologic Features in Prostate Cancer: A Multi-Institutional Study |
| Q26751983 | MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer |
| Q39401816 | PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer |
| Q40772764 | Prognostic value of Ki67 in localized prostate carcinoma: a multi-institutional study of >1000 prostatectomies |
| Q38297638 | Prostate-specific RNA aptamer: promising nucleic acid antibody-like cancer detection. |
| Q57106119 | The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation |
Search more.